tiprankstipranks
Trending News
More News >
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market
Advertisement

NRX Pharmaceuticals (NRXP) Stock Investors

Compare
578 Followers
Based on 822,356 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRXP
On average, investors allocate 2.61% of their portfolios to NRXP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 822,356 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRXP

6.8%
Last 7
Days
30.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRXP, out of 822,356 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRXP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.19%
$2.07
Closed
0.51%
$3.48
Increased
0.00%
$2.60
Increased
0.73%
$2.87
Opened
0.30%
$3.25
Opened
0.42%
$3.33
Based on the activity of investors who made their portfolios public
The table shows changes in NRXP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRXP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
4.72%
+1.86%
+4.50%
7.94B
Financial
Bristol-Myers Squibb
2.82%
+0.86%
+2.39%
90.90B
Healthcare
Ford Motor
4.63%
+1.11%
-0.29%
46.72B
Consumer Cyclical
MARA Holdings
4.47%
+1.40%
+3.64%
7.50B
Financial
Viking Therapeutics
3.69%
+0.74%
-2.48%
3.55B
Healthcare
Block
3.12%
-0.74%
-3.30%
48.17B
Technology
Crispr Therapeutics AG
3.53%
+0.81%
+3.25%
6.42B
Healthcare
Nio
5.35%
-0.59%
+1.19%
16.08B
Consumer Cyclical
Cloudflare
3.52%
-0.46%
-0.04%
75.76B
Technology
Lucid Group
4.43%
-0.32%
-1.80%
6.76B
Consumer Cyclical
Based on the activity of 822,356 active portfolios
Open your Smart Portfolio

NRXP Investor Analysis

NRXP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.2%
of NRXP holders
are under 35
Average Segment Performance
Average P/E Ratio31.13
Beta0.55
Dividend Yield4.78%
NRXP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
62.5%
of NRXP holders
are between 35–55
Average Segment Performance
Average P/E Ratio27.62
Beta5.45
Dividend Yield6.43%
NRXP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.3%
of NRXP holders
are over 55
Average Segment Performance
Average P/E Ratio25.78
Beta1.62
Dividend Yield3.76%
Overview of age group and performance of NRXP stock investors
See who invests in NRXP according to age group and performance.

FAQ

How many retail Investors hold NRXP?
<0.1% of TipRanks' retail investors hold NRXP in their portfolios.
    What is NRXP Investor Sentiment?
    NRXP’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of NRXP in the last 7 days?
      ▲ 6.8% of TipRanks' retail investors changed their holding of NRXP in the last 7 days.
        What percentage of retail investors changed their holding of NRXP in the last 30 days?
        ▲ 30.4% of TipRanks' retail investors changed their holding of NRXP in the last 30 days.
          What is the average age of retail investors who hold NRXP?
          The average age of NRXP Holders is between 35–55.
            What other stocks have NRXP investors also bought?
            NRXP Investors also bought RIOT, BMY, F, MARA, VKTX, XYZ, CRSP, NIO, NET, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis